| Title | Date | PubMed ID |
|---|
| Early glycogen synthase kinase-3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway. | 2016 Aug | 27177932 |
| AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo. | 2016 May 27 | 27230293 |
| Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β. | 2015 Jun 29 | 26119563 |
| New methods based on capillary electrophoresis for in vitro evaluation of protein tau phosphorylation by glycogen synthase kinase 3-β. | 2015 Apr | 25711986 |
| TTBK2: a tau protein kinase beyond tau phosphorylation. | 2015 | 25950000 |
| Glycogen synthase kinase-3 regulates production of amyloid-β peptides and tau phosphorylation in diabetic rat brain. | 2014 | 24983010 |
| Tau-tubulin kinase 1 expression, phosphorylation and co-localization with phospho-Ser422 tau in the Alzheimer's disease brain. | 2013 Jul | 23088643 |
| Design, synthesis, and evaluation of 3-aryl-4-pyrrolyl-maleimides as glycogen synthase kinase-3β inhibitors. | 2013 May | 23585245 |
| Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice. | 2013 May | 23294633 |
| Preferential selectivity of inhibitors with human tau protein kinase gsk3β elucidates their potential roles for off-target Alzheimer's therapy. | 2013 | 24222885 |